Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Frontiers in Bioscience (Landmark Edition)
|
May 31, 2011
Tissue factor and factor VIIa cross-species compatibility
Tom Knudsen, Ole Hvilsted Olsen, Lars Christian Petersen
Plant Disease
|
March 13, 2019
A Cerospora Leaf Spot Model for Sugar Beet: In Practice by an Industry
Carol E Windels, H Arthur Lamey, Dave Hilde, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 7, 2012
Mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay
Marianne Barrier, Kelly Chandler, Susan Jeffay, et al.
Clinical Pharmacology and Therapeutics
|
January 4, 2024
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors
Alan Faraj, Joakim Nyberg, Grant E Blouse, et al.
American Journal of Veterinary Research
|
August 2, 2011
Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa
Tom Knudsen, Marianne Kjalke, Mikael Tranholm, et al.
Blood Advances
|
November 22, 2018
Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice
Rikke Stagaard, Carsten Dan Ley, Kasper Almholt, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 3, 2022
Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug
Alan Faraj, Tom Knudsen, Shraddha Desai, et al.
Advances in Therapy
|
June 21, 2023
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients
Alan Faraj, Natacha Le Moan, Eduard Gorina, et al.
Journal of Pharmaceutical Sciences
|
June 30, 2024
Model-Based Interspecies Scaling for Predicting Human Pharmacokinetics of CB 4332, a Complement Factor I Protein
Rami Ayoun Alsoud, Natacha Le Moan, Lars Holten-Andersen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 12, 2023
Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy
Alan Faraj, Rob C van Wijk, Linda Neuman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Frontiers in Bioscience (Landmark Edition)
|
May 31, 2011
Tissue factor and factor VIIa cross-species compatibility
Tom Knudsen, Ole Hvilsted Olsen, Lars Christian Petersen
Plant Disease
|
March 13, 2019
A Cerospora Leaf Spot Model for Sugar Beet: In Practice by an Industry
Carol E Windels, H Arthur Lamey, Dave Hilde, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
June 7, 2012
Mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay
Marianne Barrier, Kelly Chandler, Susan Jeffay, et al.
Clinical Pharmacology and Therapeutics
|
January 4, 2024
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors
Alan Faraj, Joakim Nyberg, Grant E Blouse, et al.
American Journal of Veterinary Research
|
August 2, 2011
Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa
Tom Knudsen, Marianne Kjalke, Mikael Tranholm, et al.
Blood Advances
|
November 22, 2018
Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice
Rikke Stagaard, Carsten Dan Ley, Kasper Almholt, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 3, 2022
Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug
Alan Faraj, Tom Knudsen, Shraddha Desai, et al.
Advances in Therapy
|
June 21, 2023
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients
Alan Faraj, Natacha Le Moan, Eduard Gorina, et al.
Journal of Pharmaceutical Sciences
|
June 30, 2024
Model-Based Interspecies Scaling for Predicting Human Pharmacokinetics of CB 4332, a Complement Factor I Protein
Rami Ayoun Alsoud, Natacha Le Moan, Lars Holten-Andersen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 12, 2023
Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy
Alan Faraj, Rob C van Wijk, Linda Neuman, et al.
Page
of 2